Trending
- Improved CT capability will provide better resolution for hybrid imaging at St Helier’s nuclear medicine centre
- Annual inspections can help extend the life of RF doors
- Sheffield’s AI tool predicts kidney failure six times faster than human expert analysts
- Introducing the Omni Legend PETCT scanner at UCLH
- Dr Chatterjee shares POCUS expertise using Probo’s ultrasound system at Arab Health
- Urgent findings from head CT scans prioritised by AI at NHS Greater Glasgow and Clyde to support winter A&E pressures
- AXREM and RAD Magazine announce new partnership
- Northern Care Alliance deploys digital pathology with Sectra
- InHealth launches relocatable radioligand therapy service
- Helium-free innovation for a sustainable tomorrow
Modern cancer multi-disciplinary team meeting (MDTM): would it need to be modified in the post-COVID era?
Author(s): Dr G Jyoti Bansal
Hospital: Cardiff and Vale University Health Board
Reference: RAD Magazine online
Excerpt: Working in teams is a highly valued aspect of modern society. There is an increasing emphasis on teamwork and collaboration, not just in healthcare, but also in the corporate sector, academic institutions and research organisations. ‘Open plan offices’, ‘small group learning’, ‘brain storming’ and ‘face to face’ interaction are encouraged. The same cooperative approach is practiced in multi-disciplinary team meetings (MDTMs) for discussing patients with cancer. The trend for these meetings started over two decades ago and continues to gain popularity. After the recent Paterson inquiry, there was an impetus to discuss more patients including benign cases in a cancer MDTM and this trend is likely to endure. The COVID-19 pandemic has brought unprecedented challenges with an enormous impact on healthcare, and will have a long lasting impact on the functioning of MDTMs.